Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Oxelmark L, Lindberg A, Löfberg R, Sternby B, Eriksson A, Almer S, Befrits R, Fossum B, Karlén P, Broström O, Tysk C; SOIBD, the Swedish Organization for the study of Inflammatory Bowel Disease..

Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1320-8. doi: 10.1097/MEG.0000000000000710.

2.

From IBS to DBS: The Dysbiotic Bowel Syndrome.

Benno P, Dahlgren AL, Befrits R, Norin E, Hellström PM, Midtvedt T.

J Investig Med High Impact Case Rep. 2016 May 9;4(2):2324709616648458. doi: 10.1177/2324709616648458.

3.

[Underlying dysbiosis may be the cause of some forms of IBS. Patients were free of symptoms after the administration of microbiota].

Benno P, Befrits R, Berstad A, Dahlgren AL, Norin E, Midtvedt T.

Lakartidningen. 2015 Jun 2;112. pii: DF7I. Swedish.

PMID:
26035536
4.

Is irritable bowel syndrome a dysbiotic bowel syndrome?

Benno P, Befrits R, Norin E, Berstad A, Dahlgren AL, Midtvedt T, Hellström PM.

Microb Ecol Health Dis. 2015 May 29;26:27637. doi: 10.3402/mehd.v26.27637. No abstract available.

5.

Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County.

Malmborg P, Grahnquist L, Ideström M, Lindholm J, Befrits R, Björk J, Montgomery S, Hildebrand H.

Inflamm Bowel Dis. 2015 May;21(5):1098-108. doi: 10.1097/MIB.0000000000000356.

PMID:
25844958
6.

Fabry disease simulating Crohn's ileitis.

Rubio CA, Villnow E, Sundelin B, Eriksson E, Dolapcsiev K, Björk J, Befrits R, Tengvar M, Iversen H.

Anticancer Res. 2014 May;34(5):2437-41.

PMID:
24778057
7.

Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.

Kuznetsov NV, Zargari A, Gielen AW, von Stein OD, Musch E, Befrits R, Lofberg R, von Stein P.

BMC Gastroenterol. 2014 Apr 23;14:79. doi: 10.1186/1471-230X-14-79.

8.

Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment.

Marits P, Landucci L, Sundin U, Davidsdottir L, Nilsson J, Befrits R, Wikström AC, Eberhardson M.

J Crohns Colitis. 2014 Aug;8(8):881-9. doi: 10.1016/j.crohns.2014.01.009.

PMID:
24486178
9.

Naïve T cells in the gut: how to really find them?

Karlsson M, Linton L, Lampinen M, Karlén P, Glise H, Befrits R, Janczewska I, Carlson M, Winqvist O, Eberhardson M.

Scand J Gastroenterol. 2014 Apr;49(4):518. doi: 10.3109/00365521.2014.884159. No abstract available.

PMID:
24484322
10.

Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.

Karlsson M, Linton L, Lampinen M, Karlén P, Glise H, Befrits R, Janczewska I, Carlson M, Winqvist O, Eberhardson M.

Scand J Gastroenterol. 2014 Jan;49(1):66-74. doi: 10.3109/00365521.2013.853829.

PMID:
24188321
11.

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.

Stein J, Bager P, Befrits R, Gasche C, Gudehus M, Lerebours E, Magro F, Mearin F, Mitchell D, Oldenburg B, Danese S.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1456-63. doi: 10.1097/MEG.0b013e328365ca7f.

PMID:
24100539
12.

High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study.

Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF.

Scand J Gastroenterol. 2013 Nov;48(11):1286-93. doi: 10.3109/00365521.2013.838605.

PMID:
24073709
13.

Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.

Befrits R, Wikman O, Blomquist L, Hjortswang H, Hammarlund P, Bajor A, Klintman D, Blom H.

Scand J Gastroenterol. 2013 Sep;48(9):1027-32. doi: 10.3109/00365521.2013.819442.

PMID:
23889159
14.

Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis.

Tanaka K, Rubio CA, Dlugosz A, Truskaite K, Befrits R, Lindberg G, Schmidt PT.

Gastrointest Endosc. 2013 Oct;78(4):659-64. doi: 10.1016/j.gie.2013.05.025. No abstract available.

PMID:
23827349
15.

Carcinoma in gut-associated lymphoid tissue in ulcerative colitis: Case report and review of literature.

Rubio CA, Befrits R, Ericsson J.

World J Gastrointest Endosc. 2013 Jun 16;5(6):293-6. doi: 10.4253/wjge.v5.i6.293.

16.

Traditional serrated adenoma in a patient with Barrett's esophagus.

Rubio CA, Tanaka K, Befrits R.

Anticancer Res. 2013 Apr;33(4):1743-5.

PMID:
23564826
17.

HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD.

Linton L, Karlsson M, Grundström J, Hjalmarsson E, Lindberg A, Lindh E, Glise H, Befrits R, Janczewska I, Karlén P, Winqvist O, Eberhardson M.

Clin Transl Gastroenterol. 2012 Dec 20;3:e29. doi: 10.1038/ctg.2012.23.

18.
19.

Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease.

Grundström J, Linton L, Thunberg S, Forsslund H, Janczewska I, Befrits R, van Hage M, Gafvelin G, Eberhardson M.

Clin Exp Immunol. 2012 Aug;169(2):137-47. doi: 10.1111/j.1365-2249.2012.04600.x.

20.

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus.

Reinisch W, Van Assche G, Befrits R, Connell W, D'Haens G, Ghosh S, Michetti P, Ochsenkühn T, Panaccione R, Schreiber S, Silverberg MS, Sorrentino D, van der Woude CJ, Vermeire S, Panes J.

J Crohns Colitis. 2012 Mar;6(2):248-58. doi: 10.1016/j.crohns.2011.11.001.

Items per page

Supplemental Content

Loading ...
Support Center